| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |